Latest Close
$1.97
News
ACXP
Acurx Pharmaceuticals, Inc. News
This news view pulls recent coverage and headlines tied to ACXP.
1y Change
-$6.03 (-75.37%)
Market Cap
$8,466,544.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
Acurx Pharmaceuticals (NASDAQ: ACXP) Highlights FDA's New CDI Guidance That Could Accelerate Approval Path for Ibezapolstat
ACCESS Newswire • May 19, 2026
Read articleAcurx Pharmaceuticals, Inc. Q1 2026 Earnings Call Summary
Moby • May 12, 2026
Read articleAcurx Pharmaceuticals, Inc. Reports First Quarter 2026 results and Provides Business Update
PR Newswire • May 12, 2026
Read articleAcurx Announces Scientific Poster Presentation of its DNA pol IIIC Inhibitors' Microbiome Evaluation at ESCMID Global 2026
PR Newswire • May 4, 2026
Read articleAcurx Pharmaceuticals to Present at the Alliance Global Partners (A.G.P) Healthcare Company Showcase
PR Newswire • Apr 29, 2026
Read articleAcurx Pharmaceuticals, Inc. To Present at The Market Movers Investor Summit
TMX Newsfile • Apr 27, 2026
Read article